The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.
Jun 8, 2021
0
1
New research confirms that the controversial decision by Warren Buffet – the 81-year-old CEO of Berkshire Hathaway – to undergo a blood test screening for prostate cancer despite his age is hardly unusual. Despite ...
Apr 24, 2012
1
0
The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...
May 24, 2013
0
0
The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the ...
Jun 28, 2021
0
1
COVID-19 may have changed UK doctors' end-of-life decision-making, making them more willing to not resuscitate very sick and/or frail patients and raising the threshold for referral to intensive care, suggest the results ...
Jul 25, 2022
0
28
Approximately one-third of U.S. adults have hypertension (or high blood pressure). Treatment of this condition is essential to the prevention of cardiovascular disease (CVD), the #1 killer of both men and women in the country. ...
Jul 6, 2015
0
10
